Bio-pharmaceuticals
Bio-pharmaceuticals
Umbrex is pleased to welcome Sarah Dolman with Healthtech Catalyst. Sarah has 15 years of broad healthcare experience, spanning bio-pharmaceuticals, health-tech, med-tech and insurers. She has spent the last five years advising teams as they define product strategy, identify strategic investors and build deep partnerships. Sarah has experience in top-tier consulting (BCG), health-tech (Verily, f.k.a Google [X] Life Sciences) and drug-development (Merck). Sarah is most excited when projects sit at the interface of science, tech/AI, and care-delivery….
CATEGORIES
CONTRIBUTOR
tags
Popular Tags
- Aerospace & Defense
- Agriculture
- Automotive
- Biotechnology
- Branding
- Change Management
- Consumer Packaged Goods
- Cosmetics & Personal Care
- Data & Analytics
- Digital Marketing
- Digital Strategy
- Education
- Energy
- Growth Strategy
- Healthcare
- Insurance
- Lean Operations
- Manufacturing
- Media & Entertainment
- Medical Devices
- Mergers & Acquisitions
- Metals & Mining
- NonProfit
- Oil & Gas
- Operations Transformation
- Pharmaceuticals
- Pricing
- Private Equity
- Procurement
- Product Management
- Retail
- Risk Management
- Software
- Supply Chain
- Sustainability
- Talent Management
- Technology
POPULAR POSTS

Umbrex is pleased...
Jun 5, 2023An Introduction t...
Jun 5, 2023How to Caring Agi...
Jun 3, 2023